Mark J. Field

4.4k total citations
52 papers, 3.5k citations indexed

About

Mark J. Field is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Mark J. Field has authored 52 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 28 papers in Cellular and Molecular Neuroscience and 22 papers in Molecular Biology. Recurrent topics in Mark J. Field's work include Pain Mechanisms and Treatments (31 papers), Neuropeptides and Animal Physiology (16 papers) and Neuroscience and Neuropharmacology Research (11 papers). Mark J. Field is often cited by papers focused on Pain Mechanisms and Treatments (31 papers), Neuropeptides and Animal Physiology (16 papers) and Neuroscience and Neuropharmacology Research (11 papers). Mark J. Field collaborates with scholars based in United Kingdom, United States and Netherlands. Mark J. Field's co-authors include Lakhbir Singh, John Hughes, Scott McCleary, Ryszard J. Oles, L. Singh, Steve Bramwell, Joel W. Hughes, Siân Lewis, G.N. Woodruff and N.M.J. Rupniak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Pain.

In The Last Decade

Mark J. Field

51 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Field United Kingdom	29	1.8k	1.3k	1.2k	575	444	52	3.5k
Tatsuo Yamamoto Japan	31	2.1k 1.2×	1.6k 1.2×	1.0k 0.9×	405 0.7×	252 0.6×	90	3.3k
Jeffry L. Vaught United States	35	1.3k 0.7×	2.0k 1.5×	2.0k 1.7×	348 0.6×	279 0.6×	82	4.1k
Florence Noble France	39	1.4k 0.8×	3.5k 2.6×	2.4k 2.0×	613 1.1×	185 0.4×	141	5.4k
Claes Post Sweden	31	1.3k 0.7×	1.1k 0.8×	928 0.8×	282 0.5×	195 0.4×	88	3.0k
Anthony S. Basile United States	45	718 0.4×	2.8k 2.1×	2.4k 2.1×	626 1.1×	364 0.8×	148	6.0k
N S Gee United Kingdom	18	906 0.5×	1.1k 0.8×	1.2k 1.0×	219 0.4×	265 0.6×	29	2.7k
Manfred Göthert Germany	39	1.0k 0.6×	3.5k 2.7×	3.3k 2.8×	1.1k 1.9×	225 0.5×	192	6.3k
Philippe Sarret Canada	43	1.2k 0.7×	2.5k 1.9×	2.1k 1.8×	759 1.3×	196 0.4×	162	4.9k
S. Spector United States	32	729 0.4×	1.7k 1.3×	1.4k 1.2×	311 0.5×	202 0.5×	68	3.4k
Bradley V. Clineschmidt United States	32	879 0.5×	2.1k 1.6×	1.8k 1.5×	265 0.5×	172 0.4×	86	3.8k

Countries citing papers authored by Mark J. Field

Since Specialization

Citations

This map shows the geographic impact of Mark J. Field's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Field with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Field more than expected).

Fields of papers citing papers by Mark J. Field

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Field. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Field. The network helps show where Mark J. Field may publish in the future.

Co-authorship network of co-authors of Mark J. Field

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Field. A scholar is included among the top collaborators of Mark J. Field based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Field. Mark J. Field is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McIntyre, Matthew H., Achim Kless, Peter Hein, Mark J. Field, & Joyce Y. Tung. (2020). Validity of the cold pressor test and pain sensitivity questionnaire via online self-administration. PLoS ONE. 15(4). e0231697–e0231697. 18 indexed citations

Birger, Ruthie, Ricky Banarsee, David Bennett, et al.. (2011). Identification of patients with neuropathic pain using electronicprimary care records. Journal of Innovation in Health Informatics. 19(2). 83–90. 17 indexed citations

Florian, Jeffry, S. Bramwell, Mark J. Field, et al.. (2010). Pharmacokinetic–Pharmacodynamic Analysis of the Static Allodynia Response to Pregabalin and Sildenafil in a Rat Model of Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics. 334(2). 599–608. 20 indexed citations

Blakemore, David C., et al.. (2009). Synthesis and in vivo evaluation of 3-substituted gababutins. Bioorganic & Medicinal Chemistry Letters. 20(1). 362–365. 16 indexed citations

Blackbeard, J., Kieran P. O’Dea, V.C.J. Wallace, et al.. (2007). Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry. Journal of Neuroscience Methods. 164(2). 207–217. 41 indexed citations

Field, Mark J., Peter J. Cox, Heather L. Melrose, et al.. (2006). Identification of the α ₂ -δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proceedings of the National Academy of Sciences. 103(46). 17537–17542. 452 indexed citations

Corradini, Laura, et al.. (2005). Pregabalin (Lyrica®) attenuates ’anxiety-like’ behaviour in a preclinical model of neuropathic pain. Journal of Pain. 6(3). S12–S12. 1 indexed citations

Belliotti, Thomas R., Thomas Capiris, Jack J. Kinsora, et al.. (2005). Structure−Activity Relationships of Pregabalin and Analogues That Target the α₂-δ Protein. Journal of Medicinal Chemistry. 48(7). 2294–2307. 173 indexed citations

Field, Mark J., Maria Gonzalez, Ronald J. Tallarida, & Lakhbir Singh. (2002). Gabapentin and the Neurokinin1 Receptor Antagonist CI-1021 Act Synergistically in Two Rat Models of Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics. 303(2). 730–735. 29 indexed citations

10.

Field, Mark J., John Hughes, & Lakhbir Singh. (2000). Further evidence for the role of the α₂δ subunit of voltage dependent calcium channels in models of neuropathic pain. British Journal of Pharmacology. 131(2). 282–286. 93 indexed citations

11.

Field, Mark J., María Isabel González, Scott McCleary, et al.. (1999). Enadoline, a selective κ -opioid receptor agonist shows potent antihyperalgesic and antiallodynic actions in a rat model of surgical pain. Pain. 80(1). 383–389. 28 indexed citations

12.

Field, Mark J., et al.. (1999). Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?. Pain. 83(2). 303–311. 178 indexed citations

13.

Receveur, Jean‐Marie, Justin S. Bryans, Mark J. Field, Lakhbir Singh, & David C. Horwell. (1999). Synthesis and biological evaluation of conformationally restricted gabapentin analogues. Bioorganic & Medicinal Chemistry Letters. 9(16). 2329–2334. 24 indexed citations

14.

González, María Isabel, et al.. (1998). Evaluation of PD 154075, a tachykinin NK1 receptor antagonist, in a rat model of postoperative pain. European Journal of Pharmacology. 344(2-3). 115–120. 21 indexed citations

15.

Field, Mark J., et al.. (1997). Evaluation of Gabapentin and S-(+)-3-Isobutylgaba in a Rat Model of Postoperative Pain. Journal of Pharmacology and Experimental Therapeutics. 282(3). 1242–1246. 214 indexed citations

16.

Field, Mark J., Ryszard J. Oles, Siân Lewis, et al.. (1997). Gabapentin (neurontin) and S‐(+)‐3‐isobutylgaba represent a novel class of selective antihyperalgesic agents. British Journal of Pharmacology. 121(8). 1513–1522. 287 indexed citations

17.

Singh, L., Mark J. Field, John C. Hunter, et al.. (1996). The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed byd-serine. Psychopharmacology. 127(1-2). 1–9. 204 indexed citations

18.

Hinks, G.L., et al.. (1996). The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze. European Journal of Pharmacology. 312(2). 153–161. 35 indexed citations

19.

Singh, L., Ryszard J. Oles, Mark J. Field, et al.. (1996). Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine. British Journal of Pharmacology. 118(5). 1317–1325. 27 indexed citations

20.

Rupniak, N.M.J., M. J. Steventon, Mark J. Field, C.A. Jennings, & Susan D. Iversen. (1989). Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects. Psychopharmacology. 99(2). 189–195. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact